Inventor
MATSUMOTO SHIGEMITSU
JP17 patents
⚠️ This page may combine multiple inventors who share the name “MATSUMOTO SHIGEMITSU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TAKEDA PHARMACEUTICALS CO
13 patentsUS10053456B2Aug 21, 2018
Cyclopropanamine compound and use thereof
TAKEDA PHARMACEUTICALS CO3 citations84
US9718814B2Aug 1, 2017
Cyclopropanamine compound and use thereof
TAKEDA PHARMACEUTICALS CO5 citations84
US9714241B2Jul 25, 2017
Cyclopropanamine compound and use thereof
TAKEDA PHARMACEUTICALS CO5 citations84
US9487511B2Nov 8, 2016
Cyclopropanamine compound and use thereof
TAKEDA PHARMACEUTICALS CO5 citations84
US10807987B2Oct 20, 2020
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO5 citations72
US11230541B2Jan 25, 2022
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO2 citations71
US10968213B2Apr 6, 2021
Cyclopropanamine compound and use thereof
TAKEDA PHARMACEUTICALS CO0 citations62
US11713311B2Aug 1, 2023
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO1 citations61
US11702419B2Jul 18, 2023
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO1 citations61
US10414761B2Sep 17, 2019
Cyclopropanamine compound and use thereof
TAKEDA PHARMACEUTICALS CO0 citations52
US9920047B2Mar 20, 2018
Cyclopropanamine compound and use thereof
TAKEDA PHARMACEUTICALS CO0 citations52
US11952344B2Apr 9, 2024
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO0 citations50
US10968231B2Apr 6, 2021
Substituted cyclyl-acetic acid derivatives for the treatment of metabolic disorders
TAKEDA PHARMACEUTICALS CO0 citations50